Loading
EB
EastWest Bioscience Inc. Stock: price and insider trades · Canada
EastWest Bioscience Inc.: what insiders have been doing
Every trade that managers of EastWest Bioscience Inc. disclose to SEDI is tracked on this page. Nothing new has been filed by managers of EastWest Bioscience Inc. in twelve months, the latest record being from 18 September 2022.
The full history, which starts in 2018, counts 43 purchases against no sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
63
Thresholds
n/a
Buy Volume
€140,972
43 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 18 September 2022
Declarations63 total
50,000 shares@ CA$0.040.6% of flowCommon SharesTSXSEDI:4003838
Canonical exit: 14 Dec 2022 (T+90)
50,000 shares@ CA$0.040.6% of flowCommon SharesTSXSEDI:4003839
Canonical exit: 15 Dec 2022 (T+90)
64,000 shares@ CA$0.0351.4% of flowCommon SharesTSXSEDI:4000830
Canonical exit: 7 Dec 2022 (T+90)
89,000 shares@ CA$0.0352.0% of flowCommon SharesTSXSEDI:4000831
Canonical exit: 8 Dec 2022 (T+90)
940,000 shares@ CA$0.0212.5% of flowCommon SharesTSXSEDI:3982010
600,000 shares@ CA$0.028.0% of flowCommon SharesTSXSEDI:3982008
Canonical exit: 24 Oct 2022 (T+90)
16,000 shares@ CA$0.020.2% of flowCommon SharesTSXSEDI:3982001
Canonical exit: 26 Oct 2022 (T+90)
850,000 shares@ CA$0.0211.3% of flowCommon SharesTSXSEDI:3981997
Canonical exit: 25 Oct 2022 (T+90)
19,000 shares@ CA$0.020.3% of flowCommon SharesTSXSEDI:3981992
Canonical exit: 24 Oct 2022 (T+90)
600,000 shares@ CA$0.027.9% of flowCommon SharesTSXSEDI:3981240
Canonical exit: 20 Oct 2022 (T+90)
44,000 shares@ CA$0.0150.8% of flowCommon SharesTSXSEDI:3963689
Canonical exit: 15 Sept 2022 (T+90)
3,000 shares@ CA$0.0150.1% of flowCommon SharesTSXSEDI:3960558
Canonical exit: 6 Sept 2022 (T+90)
16,000 shares@ CA$0.0150.3% of flowCommon SharesTSXSEDI:3951599
Canonical exit: 7 Aug 2022 (T+90)
111,000 shares@ CA$0.021.1% of flowCommon SharesTSXSEDI:3910268
Canonical exit: 16 Jun 2022 (T+90)
300,000 shares@ CA$0.026.8% of flowCommon SharesTSXSEDI:3804048
Canonical exit: 12 Dec 2021 (T+90)
949,000 shares@ CA$0.0210.6% of flowCommon SharesTSXSEDI:3785523
Canonical exit: 2 Nov 2021 (T+90)
15,000 shares@ CA$0.020.2% of flowCommon SharesTSXSEDI:3781049
Canonical exit: 19 Oct 2021 (T+90)
36,000 shares@ CA$0.020.4% of flowCommon SharesTSXSEDI:3781048
Canonical exit: 18 Oct 2021 (T+90)
1,002,732 shares@ CA$0.0557.6% of flowCommon SharesTSXSEDI:3736167
1,516,835 shares@ CA$0.0542.4% of flowCommon SharesTSXSEDI:3736165
136,470 sharesCommon SharesTSXSEDI:3736166
21,000 sharesCommon SharesTSXSEDI:3736164
200,000 sharesCommon SharesTSXSEDI:3698356
Common SharesTSXSEDI:3698355
79,000 shares@ CA$0.031.1% of flowCommon SharesTSXSEDI:3667610
Canonical exit: 22 Apr 2021 (T+90)
25 of 63 declarations
About EastWest Bioscience Inc.
EastWest Bioscience Inc. is a Canadian company focused on the development and marketing of natural health products. It operates on the Toronto Stock Exchange (XTSE).
